Atria Wealth Solutions »

Biosante Pharmaceuticals shares owned by Atria Wealth Solutions

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Atria Wealth Solutions from 13F filings

Historical chart of Atria Wealth Solutions investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Atria Wealth Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Atria Wealth Solutions

Quarter filed Position value Share count Share price at filing
2024-09-30 $706k 12k 59.66

More positions owned by Atria Wealth Solutions

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Atria Wealth Solutions

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
State Street Corporation
Goldman Sachs Group
Dimensional Fund Advisors
Global Alpha Capital Management
Citadel Advisors
UBS Group
Ranger Investment Management
Macquarie Group
Deep Track Capital
William Blair Investment Management
Geode Capital Management
Tang Capital Management

View all funds holding Biosante Pharmaceuticals